Inactive Partial Small Business Set-Aside (FAR 19.5)

Solicitation # HHSNIHOPCSBSS-22-003276 Date Posted 2-8-2022 Date Closed 2-15-2022 This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations w... Solicitation # HHSNIHOPCSBSS-22-003276 Date Posted 2-8-2022 Date Closed 2-15-2022 This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH), Clinical Center (CC),Depatment of Transfusion Medicine (DTM) intends to solicit a quote and enter into firm-fixed price for preventive maintenance for Sequencing reagents with Illumina INC Illumina, provides the clinically approved platform for reagents, kits, and the respective instruments that may be used for patient care testing for differential gene expression analysis and tracking immunotherapy efficiency and monitoring side effects on clinical and research cellular products. The preventive maintenance is required to compliance with manufacturer and FDA 21 CFR 211.67. The NextSeq550 sequencer instrument is a unique instrument that can help us identify specific cell populations and modifications to guide and improve cell product administrated to the patient. This instrument is needed to generate data that is required for providing guidance to improve immunotherapy efficiency of the cellular therapy product. The purpose of this correspondence is to request a PO to purchase Preventive maintenance support for Illumina under citation 10 U.S.C. 2304(c) (2), 41 U.S.C. 253(c) (2) and FAR 6.302-1: Quality of product required for ongoing experiments as well as a Proprietary request/Only One Responsible Source. This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12, in conjunction with the policies and procedures for the competition requirements of Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date, FEB 15,, 2022 at 9:00 EST specified in this announcement, electronically to the attention of Priscilla Abalos, Contract Specialist, Priscilla.abalos@nih.gov by the due date and time marked in this notice.